BNTC — Benitec Biopharma Share News
0.000.00%
Last trade - 00:00- $301.79m
- $121.82m
Benitec Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Benitec Biopharma Releases Third Quarter 2023 Financial Results And Provides Operational Update
Benitec Biopharma Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Benitec Biopharma To Regain Compliance With Nasda Bid Price Rule
Benitec Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Brief: Benitec Biopharma Posts Qtrly Loss Of $0.20 Per Share
Benitec Biopharma Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Benitec Biopharma Inc - Enrolls First OPMD Subject Into Clinical Development Program
Brief: Benitec Biopharma Inc Files For Common Stock Offering Of Up To 29.81 Million Shares - SEC Filing
U.S. STOCKS ON THE MOVE-Cidara, Agora, Manchester United
U.S. STOCKS ON THE MOVE-Apple, Activision Blizzard, Manchester United
Benitec Biopharma muscle disease therapy trial on track - H.C. Wainwright
Brief: Cvi Investments Inc Reports 5.8% Passive Stake In Benitec Biopharma
Brief: Benitec Biopharma Inc Announces Closing Of $18 Mln Underwritten Public Offering
U.S. STOCKS ON THE MOVE-Akouos, Core & Main, Revance Therapeutics
Benitec Biopharma slips on pricing stock offering at discount
Brief: Benitec Biopharma Inc. Announces Pricing Of $18 Million Underwritten Public Offering
Brief: Benitec Biopharma - On Sept 6 Co, Got Letter From Nasdaq That Co Did Not Meet Minimum Bid Price Requirement Set Forth In Nasdaq Listing Rule 5550
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM